Know where your portfolio stands
Your seed-stage SaaS company is growing ARR at 3x year-over-year. Is that good? It depends on the stage, the sector, and the market. Without context, you're flying blind — and so are your LPs when they read your quarterly report.
Start your free trialA portfolio company burning $200K/month sounds alarming — until you realize they're a Series A fintech that just closed $15M and the median burn at that stage is $250K. Conversely, a company growing 50% year-over-year might sound great, but if the top quartile for their stage and sector is growing 150%, you might have a problem.
Most emerging GPs don't have access to the kind of benchmark data that large institutional funds take for granted. You're making portfolio management decisions — where to spend your time, which companies to double down on, which ones to flag for your IC — based on gut feel rather than data-driven comparisons.
And when your LPs ask how the fund is performing, reporting a 1.5x TVPI doesn't mean much in isolation. They want to know: is 1.5x good for a Fund I at this stage in a 2023 vintage? Are you top quartile, median, or below? Without benchmarks, you're leaving that question unanswered — and your LPs are drawing their own conclusions.
Compare your portfolio companies against peers at the same stage. Pre-seed companies are measured differently than Series A companies — Archstone applies the right yardstick automatically so your analysis is always relevant.
A SaaS company and a biotech company have fundamentally different metric profiles. Benchmark ARR growth against other SaaS companies, GMV against other marketplaces, and clinical milestones against other life sciences companies for meaningful comparisons.
Group your investments by vintage year, stage at entry, or sector and compare cohort performance. See whether your 2024 seed investments are outperforming your 2023 cohort at the same time horizon — a signal of whether your thesis and sourcing are improving.
Automatically flag companies performing significantly above or below benchmark ranges. Identify breakout candidates early — the company growing 3x faster than stage peers — and spot underperformers before they become write-offs.
See how your portfolio's benchmark position changes over time. A company that was median last quarter but is now top-decile is telling you something important. Trend lines overlaid on benchmark ranges make these inflection points impossible to miss.
Generate polished benchmark comparison reports for LP meetings, LPAC presentations, or internal IC reviews. Show your portfolio's performance in context — not just numbers, but numbers that mean something relative to the market.
When a company's metrics consistently rank in the top decile for their stage and sector, that's a signal to consider follow-on investment. Benchmarking turns qualitative intuition into quantitative conviction for your IC discussions.
When an LP asks "How does Fund I compare to other 2023 vintage seed funds?" you have the answer ready. Present TVPI, DPI, and IRR alongside vintage benchmarks. Context transforms a good number into a great story.
Compare your sector-focused portfolio against generalist benchmarks to see if your thesis is generating alpha. If your fintech-focused fund consistently outperforms broad seed benchmarks, that's powerful validation for fundraising your next vehicle.
Archstone aggregates anonymized benchmark data from publicly available industry reports, fund performance databases, and anonymized portfolio data across the platform. Benchmarks are segmented by stage (pre-seed, seed, Series A, Series B), sector (SaaS, fintech, healthcare, etc.), and geography so comparisons are always apples-to-apples. We update benchmarks quarterly to reflect current market conditions.
Both. At the company level, compare a specific portfolio company's ARR growth, burn rate, or revenue efficiency against peers at the same stage and sector. At the portfolio level, compare your fund's aggregate TVPI, DPI, and IRR against vintage-year benchmarks. You can also benchmark cohorts — for example, all your seed investments from 2024 against the broader seed cohort from that year.
Archstone flags companies whose metrics fall significantly above or below benchmark ranges for their stage and sector. A seed-stage SaaS company growing ARR at 4x the median gets flagged as an outperformer — useful for identifying breakout candidates early. Conversely, a company burning 2x the benchmark rate with below-median growth gets flagged for attention. You control the sensitivity thresholds.
Yes. Export benchmark comparisons as PDF or include them directly in your quarterly LP report. The LP-ready format shows your portfolio's performance in context — for example, 'Fund I TVPI of 1.8x vs. top-quartile benchmark of 1.6x for 2023 vintage seed funds.' This kind of contextual reporting builds LP confidence and differentiates your communication from GPs who just report raw numbers.
14-day free trial. No credit card required.
Start your free trial